Last 308.50 GBp
Change Today -1.75 / -0.56%
Volume 2.6K
SKP On Other Exchanges
Symbol
Exchange
London
OTC US
Frankfurt
OTC US
As of 6:25 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Keith Mansford M.Sc., Ph.D., F.R.S.C., F.I.Biol., C.Chem., C.Biol

Former Non-Executive Director and Member of Remuneration Committee, SkyePharma plc
AgeTotal Calculated CompensationThis person is connected to 22 board members in 2 different organizations across 6 different industries.

See Board Relationships
82--

Background*

Keith Mansford, M.Sc., Ph.D., F.R.S.C., F.I.Biol., C.Chem., C.Biol., D.I.C, is the Founder and Principle of Mansford Associates and has been its President since 1992. Dr. Mansford is a Professor of Biochemistry at the University of BuckinghamBuckingham's Clore Laboratory, where the research group specializes in receptor, cell based and animal models of metabolic diseases including Type II Diabetes and Obesity. From 1984 to 1992, Dr. Mansford served as Chairman of Research ...

Read Full Background

Corporate Headquarters*

46-48 Grosvenor Gardens
London, Greater London SW1W 0EB

United Kingdom

Phone: 44 20 7881 0524
Fax: 44 20 7881 1199

Board Members Memberships*

Former Chairman
Director
Former Member of Scientific Advisory Board and Director
1993-2005
Former Director
1996-N/A
Former Non-Executive Director and Member of Remuneration Committee

Education*

PhD
University Of London
PhD
Imperial College
MS
Durham University
BS
Durham University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKP:LN 308.50 GBp -1.75

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
--
Christopher Paul Blackwell B.Sc., Ph..D.Chief Executive Officer and Executive Director
Vectura Group plc
674.0K GBP
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
€276.9K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYEPHARMA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.